This session will aid dermatologists in creating appropriate management plans for patients with melanoma or at risk for the disease. Topics covered are ones encountered in daily practice, including issues regarding how to approach pigmented lesions on the face, determining which patients would benefit from genetic testing and full-body skin screening, and identifying which melanoma patients would benefit from imiquimod for treatment or sentinel lymph node mapping. This session is geared towards giving the working clinician practical information to assist in formulating management plans.
This activity has been approved by the American Board of Dermatology (ABD) for up to 30 MOC Component 2 Self-Assessment points. For more information about MOC, please visit the ABD website at www.abderm.org.
Dr. Stein / How can dermoscopy help me with pigmented lesions on the face?
Dr. Swetter / Will Artificial Intelligence (AI) replace dermatologists?
Dr. Chapman / What is the role of imiquimod in the treatment of melanoma in situ?
Dr. Kim / What are some practical tips for clinicians taking care of melanoma patients?
Dr. Kim, Dr. Chapman, and Dr. Swetter / Q&A
Dr. Leachman / Which patients would benefit from full-body skin screening?
Dr. Marchetti / Which patients would benefit from genetic testing?
Dr. Ming / Which melanoma patients would benefit from a sentinel lymph node procedure?
Dr. Chu / What are the new AJCC Staging System changes, and how will they affect my patients?
Dr. Ming, Dr. Chu, Dr. Leachman, and Dr. Marchetti / Q&A